Breast cancer is the most common malignancy among women in the United States, accounting for 30% of female cancers, with an estimated 281,550 new cases and 43,600 deaths in 2021, respectively 1. Thus, ...
We collected data retrospectively on 53 patients diagnosed with breast NET from the Oulu University Hospital and Helsinki University Hospital from January 2006 to December 2018. The diagnoses were ...
The preliminary efficacy and safety results of neoadjuvant phase II study of anlotinib plus tislelizumab combined with chemotherapy in triple-negative breast cancer. This is an ASCO Meeting Abstract ...
Now, Harvard Medical School researchers based in the Laboratory of Systems Pharmacology at the Blavatnik Institute and the Massachusetts General Hospital have carried out the first head-to-head ...
Utility of breast MRI for patients with breast-cancer scheduled for breast-conserving surgery. Background: Patients with biopsy-proven Stage I and Stage II breast cancer usually undergo pre-operative ...
Breast cancer has been the most commonly diagnosed cancer among women worldwide for years running, but GLP-1s may help. The ...
Over 100,000 overweight women were studied, and those on GLP-1 medications saw an absolute breast cancer risk reduction of 0.69% during the study period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results